|
2021
|
Invention
|
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopro... |
|
2020
|
Invention
|
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease.... |
|
2019
|
Invention
|
Synthetic method for the preparation of an alkoxymethylene-benzoylacetonitrile.
Provided is a pr... |
|
|
Invention
|
Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound. Provide... |
|
|
Invention
|
Synthetic method for the preparation of an hydrazine compound.
Provided is a process for prepari... |
|
|
Invention
|
Synthetic method for the preparation of an hydrazine compound. Provided is a process for preparin... |
|
|
Invention
|
Synthetic methodfor the preparation of an alkoxymethylene-benzoylacetonitrile. Provided is a proc... |
|
2018
|
Invention
|
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevent... |
|
|
Invention
|
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatme... |
|
2017
|
Invention
|
Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-n-cyclopr... |
|
2016
|
Invention
|
Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmo... |
|
|
Invention
|
Dosage regimen for the treatment of acute exacerbations of inflammatory conditions. This inventio... |
|
2013
|
Invention
|
5-membered heterocycle-based p38 kinase inhibitors. Provided are 5-membered heterocycle-based p38... |
